title: Cost Effectiveness of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in China.
authors.affiliation: Pfizer China, Shanghai, China.
authors.forename: Q
authors.initials: Q
authors.lastname: Shi
authors.affiliation: Philadelphia College of Osteopathic Medicine-Georgia Campus, Suwanee, GA, USA.
authors.forename: H
authors.initials: H
authors.lastname: Yin
authors.affiliation: Fudan University, School of Public Health, Shanghai, China.
authors.forename: J
authors.initials: J
authors.lastname: Xuan
authors.affiliation: Foshan food and drug inspection testing center, Foshan City, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Wu
authors.affiliation: Jinan University, Guangzhou, China.
authors.forename: G
authors.initials: G
authors.lastname: Cheng